# Bolt Biotherapeutics Posts Q3 GAAP Loss of $2.25 Per Share

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/56057
Published: 2026-11-12T23:46:02.000Z
Updated: 2026-11-12T23:46:02.000Z
Section: Business

> The Nasdaq-listed company trades under the symbol BOLT.

Bolt Biotherapeutics, Inc. posted third-quarter GAAP earnings per share of -$2.25. The figure represents a loss of $2.25 per share.